Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Entecavir“
Suchtreffer
Begriffe & Kennungen
Entecavir Viatris (previously Entecavir Mylan) · 4.3 Contraindications · 1
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.5 · Entecavir is not a substrate, an inducer or an inhibitor of cytochrome P450 (CYP450) enzymes (see section 5.2)
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.5 · Interaction studies have only been performed in adults.
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.5 · No pharmacokinetic interactions between entecavir and lamivudine, adefovir or tenofovir were observed.
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.5 · Paediatric population
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.5 · Since entecavir is predominantly eliminated by the kidney (see section 5.2), coadministration with medicinal p
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.8 Undesirable effects · 1
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.8 · 8 Immune system disorders: rare: anaphylactoid reaction
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.8 · 9 In the clinical trials entecavir treatment was discontinued if patients achieved a prespecified response. If
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.8 · Adverse reactions considered at least possibly related to treatment with entecavir are listed by body system o
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.8 · Assessment of adverse reactions is based on experience from postmarketing surveillance and four clinical trial
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.8 · Cases of lactic acidosis have been reported, often in association with hepatic decompensation, other serious m
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.8 · Description of selected adverse reactions
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.8 · Exacerbations after discontinuation of treatment Acute exacerbations of hepatitis have been reported in patien
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.8 · Exacerbations during treatment In studies with nucleoside naive patients, on treatment ALT elevations >10 time
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.8 · Experience in patients co-infected with HIV The safety profile of entecavir in a limited number of HIV/HBV co-
Eintrag öffnen